In conjunction with the commercial launch of the product in the Netherlands, CooperVision released last week the results of the ongoing clinical trial on the performance of its SightGlass Vision lenses in terms of myopia progression reduction after two years of research.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.